Kaléo Agrees to $12.7 Million Settlement for Alleged Fraud and Kickbacks in Prescriptions for Anti-Overdose Drug

ShotPrime Studio | Shutterstock
Kaléo Inc. will pay $12.7 million to resolve allegations that the pharmaceutical manufacturer was involved in the submission of false claims to federal healthcare programs for its anti-overdose drug Evzio, and paid kickbacks for prescribing the drug instead of less expensive alternatives. Evzio is an injectable form of naloxone hydrochloride, which is used as counteragent […]
Must be a Paid Member or a Free Trial Member to Access Content. Members log in here.